RxSight, Inc. (NASDAQ: RXST) reported Q2 EPS of ($0.11), $0.25 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $33.74 million versus the consensus estimate of $32.21 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.